Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* |
Title | Coagulant Therapeutics | Developing Acute Bleeding |
Description | CT-001 – A Novel Factor Developing medicines to treat acute bleeding through expertise and experience in both the coagulation cascade and |
Keywords | N/A |
WebSite | coagulanttherapeutics.com |
Host IP | 198.185.159.144 |
Location | United States |
Site | Rank |
US$2,298,737
Last updated: 2023-05-18 03:46:47
coagulanttherapeutics.com has Semrush global rank of 4,604,400. coagulanttherapeutics.com has an estimated worth of US$ 2,298,737, based on its estimated Ads revenue. coagulanttherapeutics.com receives approximately 265,239 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, coagulanttherapeutics.com is safe to visit. |
Purchase/Sale Value | US$2,298,737 |
Daily Ads Revenue | US$2,122 |
Monthly Ads Revenue | US$63,658 |
Yearly Ads Revenue | US$763,888 |
Daily Unique Visitors | 17,683 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
coagulanttherapeutics.com. 600 | A | coagulanttherapeutics.com. 600 | IP: 198.185.159.144 |
coagulanttherapeutics.com. 600 | A | coagulanttherapeutics.com. 600 | IP: 198.185.159.145 |
coagulanttherapeutics.com. 600 | A | coagulanttherapeutics.com. 600 | IP: 198.49.23.144 |
coagulanttherapeutics.com. 600 | A | coagulanttherapeutics.com. 600 | IP: 198.49.23.145 |
coagulanttherapeutics.com. 3600 | NS | coagulanttherapeutics.com. 3600 | NS Record: ns57.domaincontrol.com. |
coagulanttherapeutics.com. 3600 | NS | coagulanttherapeutics.com. 3600 | NS Record: ns58.domaincontrol.com. |
coagulanttherapeutics.com. 3600 | MX | coagulanttherapeutics.com. 3600 | MX Record: 0 coagulanttherapeutics-com.mail.protection.outlook.com. |
coagulanttherapeutics.com. 3600 | TXT | coagulanttherapeutics.com. 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
0 Skip to Content Acute Bleeding The Science About Our Team News Partner Contact Open Menu Close Menu Acute Bleeding The Science About Our Team News Partner Contact Open Menu Close Menu Acute Bleeding The Science Folder: About Back Our Team News Partner Contact Coagulant Therapeutics is developing medicines to treat acute bleeding , an unmet medical need that includes postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma, through it’s expertise and experience in both the coagulation cascade and biologics. Acute bleeding is an unmet need with no approved treatments. The leading cause of death ages 1-46 is Acute Bleeding associated with traumatic injury* 20-40% of hemorrhage related deaths are potentially preventable with rapid hemostatic control** There are currently no approved drugs to treat acute bleeding More about acute bleeding *Centers for Disease Control and Prevention, National Center for Injury Prevention and Control **Tisherman et al., 2015. Ann |
HTTP/1.1 301 Moved Permanently Age: 22256 Date: Thu, 12 May 2022 02:10:29 GMT Location: https://www.coagulanttherapeutics.com/ Server: Squarespace Set-Cookie: crumb=BRx+RwtZu9xWNjRkNDM3N2U0N2ZhZmE3NjJhNWMwNjJmOWI1NzNk;Path=/ X-Contextid: 7aPsqIYT/IKo4fiDc HTTP/2 200 accept-ranges: bytes age: 15834 content-type: text/html;charset=utf-8 date: Thu, 12 May 2022 03:57:31 GMT etag: W/"90e389609c7c25c544cadd6eb0d9c9c4" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BRwSQvZc2EN3YjVjNzcxMTRmN2M4MGExYTgzMDJhZjY1ZDc1NzI5;Path=/ strict-transport-security: max-age=43200 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: 1xyvz2Zu/CU0sQ4Cn content-length: 40272 |
Domain Name: COAGULANTTHERAPEUTICS.COM Registry Domain ID: 2074736886_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-11-23T03:41:20Z Creation Date: 2016-11-16T22:44:00Z Registry Expiry Date: 2023-11-16T22:44:00Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS57.DOMAINCONTROL.COM Name Server: NS58.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-12T08:28:09Z <<< |